Mizuho Securities Reports Teva Pharmaceutical (TEVA) Upgrade and $30.00 Target, Viacom Class B (VIAB) Shorts Raised By 36.36%

June 19, 2017 - By Ellis Scott

Viacom Class B (NASDAQ:VIAB) had an increase of 36.36% in short interest. VIAB’s SI was 14.49M shares in June as released by FINRA. Its up 36.36% from 10.63M shares previously. With 8.15M avg volume, 2 days are for Viacom Class B (NASDAQ:VIAB)’s short sellers to cover VIAB’s short positions. The SI to Viacom Class B’s float is 4.08%. The stock increased 0.31% or $0.11 on June 16, reaching $35.07. About shares traded. Viacom, Inc. (NASDAQ:VIAB) has declined 8.36% since June 19, 2016 and is downtrending. It has underperformed by 25.06% the S&P500.

Among 25 analysts covering Teva Pharma (NYSE:TEVA), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Teva Pharma has $86 highest and $25 lowest target. $55.50’s average target is 79.50% above currents $30.92 stock price. Teva Pharma had 60 analyst reports since July 21, 2015 according to SRatingsIntel. Goldman Sachs maintained the stock with “Buy” rating in Monday, August 10 report. The firm has “Neutral” rating by Cantor Fitzgerald given on Friday, June 16. The firm has “Buy” rating given on Monday, July 18 by HSBC. On Tuesday, July 21 the stock rating was maintained by Leerink Swann with “Outperform”. The firm earned “Buy” rating on Monday, July 27 by Maxim Group. The company was maintained on Wednesday, November 16 by RBC Capital Markets. The rating was maintained by Maxim Group with “Hold” on Monday, February 13. The firm has “Neutral” rating given on Tuesday, September 29 by Nomura. Oppenheimer maintained the shares of TEVA in report on Thursday, July 14 with “Outperform” rating. The firm has “Outperform” rating by Maxim Group given on Thursday, March 30.

Viacom Inc. offers global media brands that create television programs, motion pictures, short-form content, applications, games, consumer products, social media experiences and other entertainment content. The company has market cap of $14.31 billion. As of September 30, 2016, the Company offered its services for audiences in more than 180 countries. It has a 11.63 P/E ratio. The Firm operates through two divisions: Media Networks and Filmed Entertainment.

Among 30 analysts covering Viacom Inc. (NASDAQ:VIAB), 13 have Buy rating, 1 Sell and 16 Hold. Therefore 43% are positive. Viacom Inc. had 80 analyst reports since August 7, 2015 according to SRatingsIntel. FBR Capital maintained Viacom, Inc. (NASDAQ:VIAB) rating on Wednesday, November 25. FBR Capital has “Outperform” rating and $65 target. The firm has “Buy” rating given on Thursday, October 13 by Bank of America. On Tuesday, December 13 the stock rating was downgraded by RBC Capital Markets to “Underperform”. The company was upgraded on Monday, January 9 by Guggenheim. Wunderlich maintained it with “Buy” rating and $56 target in Friday, October 21 report. The firm earned “Buy” rating on Wednesday, September 21 by Wunderlich. Wells Fargo upgraded Viacom, Inc. (NASDAQ:VIAB) on Thursday, February 9 to “Outperform” rating. The firm has “Hold” rating given on Wednesday, December 23 by Topeka Capital Markets. Deutsche Bank maintained the stock with “Hold” rating in Monday, May 2 report. The stock has “Buy” rating by Wunderlich on Friday, June 17.

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The company has market cap of $32.69 billion. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. It has a 292.66 P/E ratio. The Firm operates through two divisions: Generic medicines and Specialty medicines.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: